Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone [0.03%]
由 kratom 引起的肝酶升高以及随后使用纳曲酮诱发的阿片类药物戒断症状
Aimee N Jensen,Quynh-Nhu Truong,Melanie Jameson et al.
Aimee N Jensen et al.
Kratom is an herbal supplement that has gained popularity for recreational use within the United States. Kratom exerts opioid-like effects and, although not US FDA approved, is commonly used for self-treatment of pain, withdrawal management...
Erika E Tillery,Katie D Ellis,Tiffaney B Threatt et al.
Erika E Tillery et al.
Introduction: The ketogenic diet (KD) is a high-fat, low-carbohydrate, and moderate-protein diet that has shown benefit as a treatment in neurologic disorders and may serve as a therapeutic option in individuals with psyc...
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action [0.03%]
回溯往昔，探究氯胺酮的抗抑郁机制：聚焦作用机制假说
Madison N Irwin,Amy VandenBerg
Madison N Irwin
Introduction: MDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NM...
Veteran adherence to oral versus injectable AUD medication treatment [0.03%]
老年酒精使用障碍患者口服和注射药物治疗的依从性研究
Hayden Stewart,Brian G Mitchell,Daniel Ayanga et al.
Hayden Stewart et al.
Introduction: AUD medication treatment has been shown to improve outcomes compared with placebo when confined to per-protocol analysis. The same outcomes, however, have not always been maintained in intent-to-treat analys...
Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access [0.03%]
专科药房融入神经病学门诊可提高哌姆贝辛的使用率
Sabrina Livezey,Nisha B Shah,Robert McCormick et al.
Sabrina Livezey et al.
Introduction: Access to pimavanserin, the only Parkinson disease-related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiati...
Effectiveness of a clinical decision-support tool on adherence to prescribing and practice guidelines of high-risk antidepressant medications in geriatric patients [0.03%]
一种针对老年高风险抗抑郁药物临床决策支持工具的有效性研究：提高医嘱和实践指南的依从性
Madeline A VanDaele,Jordan O Smith,Jessica Bovio Franck
Madeline A VanDaele
Introduction: TCAs and paroxetine, a SSRI, are associated with safety risks in geriatric patients because of anticholinergic properties. The purpose of this project was to evaluate the impact of a clinical decision-suppor...
Andrew Kluemper,Lauren Heath,Danielle Loeb et al.
Andrew Kluemper et al.
Introduction: Depression is one of the most common mental illnesses in the United States and is often treated in primary care settings. Despite its prevalence, depression remains underdiagnosed and undertreated for a vari...
Amy VandenBerg,Erica A K Davis
Amy VandenBerg
Christine Lee,Annabelle Wanson,Sarah Frangou et al.
Christine Lee et al.
The interaction between methadone and central nervous system depressants can cause serious adverse effects, including profound sedation, respiratory depression, coma, and death. This poses a challenge in the treatment of patients with concu...
Survey of prescriptive authority among psychiatric pharmacists in the United States [0.03%]
美国精神病药剂师处方权调查
Kelly C Lee,Richard J Silvia,Carla D Cobb et al.
Kelly C Lee et al.
Introduction: Despite the high prevalence of those with mental illnesses, there is a critical shortage of psychiatric providers in the United States. Psychiatric pharmacists are valuable members of the health care team wh...